Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease

Journal of Parkinson's Disease

Volumn 5, Issue 1, 2015, Pages 117-124

  Caviness, John N ^a   Hentz, Joseph G ^a   Belden, Christine M ^b   Shill, Holly A ^b   Driver Dunckley, Erika D ^a   Sabbagh, Marwan N ^b   Powell, Jessica J ^b   Adler, Charles H ^a  

^a MAYO CLINIC   (United States)

^b BANNER HEALTH   (United States)

Author keywords

biological markers; dementia; electroencephalography; Parkinson's disease

Indexed keywords

LEVODOPA;

AGED; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; BRAIN ELECTROPHYSIOLOGY; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DELTA RHYTHM; DEMENTIA; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PARKINSON DISEASE; QUANTITATIVE ANALYSIS; REY AUDITORY VERBAL LEARNING TEST; THETA RHYTHM; UNITED STATES; AGE; COGNITION DISORDERS; COMPLICATION; FOURIER ANALYSIS; LEARNING; MENTAL HEALTH; PHYSIOLOGY; STATISTICAL MODEL; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN WAVES; COGNITION DISORDERS; COHORT STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; FOURIER ANALYSIS; HUMANS; LINEAR MODELS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; VERBAL LEARNING;

EID: 84923191647     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140480     Document Type: Article

References (25)

1. Biomarkers Definitions Working Group (2001) Biomarker and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther, 69, 89-95.
2. McGhee DJ, Royle PL, Thompson PA, Wright DE, Zajicek JP, & Counsell CE (2013) A systematic review of biomarkers for disease progression in Parkinson's disease. BMC Neuro, 13, 35.
3. Caviness JN, Lue L, Adler CH, & Walker DG (2011) Parkinson's disease dementia and potential therapeutic strategies. CNS Neurosci Ther, 17, 32-44.
4. Sirakov AA, & Mezan IS (1963) EEG findings in Parkinsonism. Electroencephalogr Clin Neurophysiol, 15, 321-322.
5. Serizawa K, Kamei S, Morita A, Hara M, Mizutani T, Yoshihashi H, Yamaguchi M, Takeshita J, & Hirayanagi (2008) Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol, 25, 361-366.
6. Soikkeli R, Partanen J, Soininen H, Paakkonen A Sr, &Riekkinen P (1991) Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol, 79, 159-165.
7. Neufeld MY, Inzelberg R, & Korczyn AD (1988) EEG in demented and non-demented parkinsonian patients. Acta Neurol Scand, 78, 1-5.
8. Neufeld MY, Blumen S, Aitkin I, Parmet Y, & Korczyn AD (1994) EEG frequency analysis in demented and non-demented parkinsonian patients. Dementia, 5, 23-28.
9. Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, Conner DJ, Sabbagh MN, Shill HA, & Adler CH (2007) Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord, 13, 348-354.
10. Fonseca LC, Tedrus GM, Letro GH, & Bossoni AS (2009) Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson's disease. Clin EEG Neurosci, 40, 168-172.
11. Vecchio F, Babiloni C, Lizio R, Fallani Fde V, Blinowska K, Verrienti G, Frisoni G, & Rossini PM (2013) Resting state cortical EEG rhythms in Alzheimer's disease: Toward EEG markers for clinical applications: A review. Suppl Clin Neurophysiol, 62, 223-236.
12. Lehtovirta M, Partanen J, Kononen M, Hiltunen J, Helisalmi S, Hartikainen P, Riekkinen P, & Soininen H (2000) A longitudinal quantitative EEG study of Alzheimer's disease: Relation to apolipoprotein E polymorphism. Dement Geriatr Cogn Disord, 11, 29-35.
13. Klassen B, Hentz J, Shill H, Driver-Dunckley E, Evidente V, Sabbagh M, Adler CH, & Caviness JN (2011) Quantitative electroencephalography as a predictor for Parkinson's disease dementia. Neurology, 77, 118-124.
14. Olde Dubbelink KTE, Stoffers D, Deijen JB, Twisk JWR, Stam CJ, & Berendse HW (2013) Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: A longitudinal study. Neurobiol Aging, 34, 408-418.
15. Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MA, Jacobsen SA, Belden CM, & Dugger BN (2014) Low clinical diagnostic accuracy of early vs advanced Parkinson's disease: Clinicopathologic study. Neurology, 83, 1-7.
16. Hughes AJ, Ben-Shlomo Y, Daniel SE, & Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology, 42, 1142-1146.
17. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litwan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, & Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord, 22, 1689-1707.
18. Rouleau I, Salmon DP, Butters N, Kennedy C, & McGuire K (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn, 18, 70-87.
19. Amzica F, & Lopes Da Silva F (2009) Cellular substrates of brain rhythms. In: Electroencephalography, sixth ed., Shomer D, Lopes Da Silva F, eds. Lippincott, Williams and Wilkins, New York, pp. 33-63.
20. Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Stam CJ, & Berendse HW (2008) Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: An MEG study. Neuroimage, 41, 212-222.
21. Tessitore A, Esposito F,Vitale C, Santangelo G, Amboni M, &Russo A (2012) Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology, 79, 1-7.
22. Ponsen MM, Stam CJ, Bosboom JLW, Berendse HW, & Hillebrand A (2013) A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming. Neuroimage, 2, 95-102.
23. Olde Dubbelink KTE, Hillebrand A, Stoffers D, Deijen JB, Twisk JWR, Stam CJ, & Berendse HW (2014) Disrupted brain network topology in Parkinson's disease: A longitudinal magnetoencephalography study. Brain, 137, 197-207.
24. Fogelson N, Kogan E, Korczyn AD, Giladi N, Shabtai H, &Neufeld MY (2003) Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients. Acta Neurol Scand, 107, 252-255.
25. Caviness JN, Adler CH, Hentz JG, Shill HA, Evidente VG, Driver-Dunckley ED, Sabbagh MN, Sue L, & Beach TG (2011) Electrophysiological biomarkers of incidental Lewy body disease. Clin Neurophysiol, 122, 2426-2432.